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EDITORIAL POINT OF VIEW
Physiologic risk assessment in stable ischemic
heart disease: still superior to the anatomic
angiographic approach
Alessia Gimelli, MD, Paolo Marzullo, MD, FESC, and Daniele Rovai, MD, FESC
In patients with ischemic heart disease (IHD), a
functional risk assessment based on non-invasive tests
may conflict with a health care policy oriented toward
cost containment and direct reperfusion delivery. In this
respect, a survey of the European Society of Cardiology
has shown that noninvasive tests are underutilized, with
wide variability between different countries,1 so that
several patients without significant IHD directly undergo
invasive coronary angiography. On the other hand,
coronary lesions detected by coronary angiography often
are revascularized even without the evidence that myo-
cardial blood supply or mechanical function is altered.2
This ‘‘anatomically oriented’’ invasive approach may
negatively impact patient management, with consequent
suboptimal medical treatment, inappropriate revascu-
larizations, additional risks, and increased health costs.
To investigate the prognostic power of gated SPECT
in current practice, we recently studied a cohort of 676
consecutive patients admitted for known or suspected
IHD.3 Each patient underwent a complete diagnostic
work-up that included clinical evaluation, laboratory
tests, 12-lead electrocardiogram, two-dimensional echo-
cardiography, stress/rest gated SPECT, and coronary
angiography. During follow-up (median, 37 months), 24
patients died from cardiac causes and 19 had a nonfatal
myocardial infarction (MI). Several variables were
independent predictors of event-free survival (cardiac
death and non-fatal MI) in the different phases of diag-
nostic work-up. When the above predictors were tested
together, summed rest score (SRS), summed difference
score (SDS), serum creatinine, and LDL/HDL cholesterol
were the only final independent predictors of event-free
survival (Table 1). The results of this study lead us to
make some considerations on risk stratification in stable
IHD.
FUNCTIONAL RISK ASSESSMENT VS INVASIVE
CORONARY ANGIOGRAPHY
The prognostic power of angiographic coronary
anatomy has been definitively established. In the CASS
registry,4 the 12-year survival rate of medically treated
patients with no significant coronary lesions was 91%,
compared with 74%, 59%, and 50% for patients with one-
, two-, and three-vessel disease. Survival rate is known to
further decrease in the presence of left main coronary
artery disease and severe proximal left anterior descend-
ing stenosis.5 To predict patient survival, we used an
angiographic semi-quantitative score, which takes into
account the number of stenotic coronary arteries, the
location of coronary stenoses (proximal, middle, or dis-
tal), and the degree of luminal diameter reduction (using a
50% and 70% coronary stenosis threshold). As expected,
this score was an independent predictor of event-free
survival. However, the prognostic impact of this score
disappeared once gated SPECT variables were included
into the model.3
The notion that the prognostic impact of functional
risk assessment is superior to angiography is not novel.
In patients with defined coronary artery disease, exercise
variables primarily relating to the functional state are
known to provide incremental prognostic information
over coronary anatomy.6 The treadmill score also adds
independent prognostic information to that provided by
clinical data, coronary arteriography, and left ventricular
(LV) ejection fraction.7 The predictive power of clini-
cal data also is strengthened by adding the results of
dobutamine echocardiography8 and, to a minor degree,
coronary anatomy data. In a group of patients who
underwent stress echocardiography with dipyridamole
or dobutamine, and who underwent coronary angiogra-
phy within a year without an intervening procedure,
coronary angiography parameters did not add significant
predictive power to the model compared with stress
echocardiographic variables.9 As for nuclear cardiology,
the superiority of myocardial perfusion imaging com-
pared with coronary angiography in risk stratification of
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patients with IHD is also well known. In 1992, Pollock
et al demonstrated that myocardial perfusion is superior
to coronary angiography in risk stratification of IHD
patients10; at variance with our study, these authors used
201-Tl and static planar imaging. In a series of 316
medically treated patients, Iskandrian et al11 showed
the independent and incremental prognostic information
of exercise SPECT thallium imaging even when cathe-
terization data are available. All of these evidences
definitively underline the superiority of functional risk
stratification compared with an approach based solely on
angiographic coronary anatomy.
Past and present observations can be partly explained
by the limitations of coronary angiography, which has
limited sensitivity compared with necropsy studies12 and
intravascular ultrasound investigations.13 Furthermore,
the identification of significant lesions may be con-
founded by coronary remodeling and by the extraluminal
location of some plaques.14 Finally, coronary angiogra-
phy gives no information on coronary microvascular
dysfunction, increasingly recognized as independent
determinant of impaired blood flow, disease progression,
and adverse prognosis.15
FUNCTIONAL RISK ASSESSMENT VS
NONINVASIVE CORONARY ANGIOGRAPHY
The prognostic value of coronary artery calcium
(CAC) has been consistently demonstrated in large series
of patients.16-18 Current evidence also suggests that the
use of CAC is independently predictive of outcome over
and above traditional cardiac risk factors. Concerning
functional risk assessment, CAC scores are predictive of a
higher likelihood of ischemia on PET myocardial perfu-
sion imaging.19 More importantly, patients with and
without ischemia on PET perfusion imaging exhibit a
stepwise increase in their risk of cardiac events with
increasing calcium scores. These findings suggest that
imaging approaches that combine quantitative informa-
tion on the anatomic burden of IHD with its physiological
consequences offer improved risk stratification compared
with conventional approaches that use myocardial per-
fusion alone. However, an independent and incremental
prognostic value of CAC compared with clinical, elec-
trocardiographic, laboratory, echocardiographic, and
angiographic variables has not been demonstrated yet.
A similar consideration applies to computed
tomography (CT) of the coronary arteries. Although the
presence of obstructive coronary lesions at 64-slice CT
angiography was a predictor of an adverse outcome
compared with the patients with normal coronary arter-
ies,20 an independent and incremental prognostic value
of CT angiography compared with clinical and scinti-
graphic variables has not been demonstrated. To the best
of our knowledge, two studies have been designed to test
the impact of a combined anatomic and functional non-
invasive imaging for detection and characterization of
IHD: the EVINCI study in Europe and the SPARC trial in
the United States of America. While we are waiting for
the results of these two studies, patients’ outcome in
stable IHD should be estimated using the evidences so far
collected.
MYOCARDIAL PERFUSION IMAGING
AND REVASCULARIZATION
In the COURAGE trial, no difference in the com-
posite of death, acute MI, and stroke was found between
patients with stable IHD, objective evidence of ischemia,
and significant coronary stenoses randomized to optimal
medical therapy with or without percutaneous coro-
nary intervention.21 The relationship between extent of
myocardial ischemia at gated SPECT and coronary
revascularization has been explored in a subset of patients
enrolled in the COURAGE nuclear substudy.22 In these
patients, the addition of percutaneous coronary interven-
tion to optimal medical therapy resulted in more effective
reduction of ischemia than optimal medical therapy alone;
this greater reduction in ischemic burden was associated
with improvements in angina class and less reliance on
nitrate therapy for symptom relief. Moreover, patients
with moderate to severe ischemia randomized to percu-
taneous coronary intervention plus optimal medical
therapy more commonly experienced a significant
reduction in ischemia at follow-up compared with those
receiving optimal medical therapy (78% vs 52%). The
results of the nuclear substudy suggest that gated SPECT
could be utilized for the identification of patients who will
benefit more from coronary revascularization.
Table 1. Independent predictors of event-free
survival using multivariate analysis, considering
all stages of diagnostic workup
Variable HR 95% CI v2 P value
SRS 1.16 1.08-1.25 16.43 .0001
SDS 1.15 1.03-1.27 6.5 .0108
Creatinine
level
2.51 1.18-4.79 5.54 .0186
LDL/HDL
cholesterol
level
1.53 1.06-2.16 5.23 .0222
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PROPER DIAGNOSTIC WORK-UP
In patients with stable IHD, myocardial perfusion
imaging may be sometimes regarded as an unnecessary,
or even redundant investigation. Our study shows that
myocardial perfusion imaging at rest and after stress is
still the best predictor of cardiac event-free survival,
even compared with an extensive diagnostic workup.
Specifically, when gated SPECT data were added to
the clinical, laboratory, electrocardiographic, and echo-
cardiographic variables, the prognostic stratification
significantly improved; however, when coronary angi-
ography was added to gated SPECT, prognostic strat-
ification did not further improve (Figure 1, top panel).
On the other hand, if the information provided by gated
SPECT was made available after clinical, laboratory,
electrocardiographic, echocardiographic, and angiographic
variables, the prognostic stratification still improved
significantly (Figure 1, lower panel). Thus, gated SPECT
carries out prognostic information that is greater than that
provided by coronary angiography. This observation
suggests that the indications for myocardial perfusion
imaging in risk stratification of patients with known or
suspected IHD should be broadened.
For several years, we have adopted the internal
policy that the information regarding LV function,
myocardial viability, and ischemia has to be available
whenever possible before coronary angiography, as it
was provided by gated SPECT in 92% of our study
patients.
CONCLUSIONS
Several lines of evidence, collected with different
approaches, demonstrate that a physiologic risk assess-
ment is superior to an angiographically oriented approach
in prognostic stratification of patients with stable IHD. In
the authors view, stress/rest myocardial perfusion abnor-
malities should be known—whenever possible—before
coronary angiography to guide decision making, provided
that appropriateness and patient’s risk/benefits ratio are
correctly considered.
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